Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/40141
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVerleye, Arno-
dc.contributor.authorWijtvliet, Veerle-
dc.contributor.authorABRAMS, Steven-
dc.contributor.authorHellemans, Rachel-
dc.contributor.authorBougrea, Rania-
dc.contributor.authorMassart, Annick-
dc.contributor.authorPipeleers, Lissa-
dc.contributor.authorWissing, Karl Martin-
dc.contributor.authorAriën, Kevin K-
dc.contributor.authorDe Winter, Benedicte Y-
dc.contributor.authorVan Damme, Pierre-
dc.contributor.authorAbramowicz, Daniel-
dc.contributor.authorLedeganck, Kristien J-
dc.date.accessioned2023-05-24T08:50:13Z-
dc.date.available2023-05-24T08:50:13Z-
dc.date.issued2022-
dc.date.submitted2023-05-22T14:32:06Z-
dc.identifier.citationNephrology, dialysis, transplantation, 37 (8) , p. 1566 -1575-
dc.identifier.urihttp://hdl.handle.net/1942/40141-
dc.description.abstractBackground.Inthegeneralpopulation,theseroconversion rateafterprimaryvaccinationwithtwodosesofanantisevereacuterespiratorysyndromecoronavirus2messenger RNA(mRNA)vaccinereachesnearly100%,withsignificantly higherantibodytitersaftermRNA-1273vaccinationcompared toBNT162b2vaccination.Hereweperformedasystematic reviewandmeta-analysistocomparetheantibodyresponse aftertwo-dosemRNA-1273versusBNT162b2vaccinationin solidorgantransplant(SOT)recipients. Methods.Asystematicliteraturereviewwasperformedusing PubMed,WebofScienceandtheCochraneLibraryand originalresearchpaperswereincludedforameta-analysisto calculatevaccine-specificseroconversionratesforeachofthe mRNAvaccines.Next,thepooledrelativeseroconversionrate wasestimated. Results.Eightstudiesthatdescribedthedevelopmentofantibodiesagainstreceptor-bindingdomain(RBD)and/orspike proteinwereeligibleformeta-analysis.Twoofthesestudies alsoreportedantibodytiters.Themeta-analysisrevealedlower seroconversionratesinSOTrecipientsvaccinatedwithtwo dosesofBNT162b2{44.3%[95%confidenceinterval(CI) 34.1–54.7]}ascomparedwithpatientsvaccinatedwithtwo dosesofmRNA-1273[58.4%(95%CI47.2–69.2)].Therelative seroconversionratewas0.795(95%CI0.732–0.864). Conclusions.Thissystematicreviewandmeta-analysis indicatesthatinSOTrecipients,higherseroconversionrates wereobservedaftervaccinationwithmRNA-1273compared withBNT162b2.-
dc.description.sponsorshipNofundingwasreceivedtoassistwiththepreparationofthis manuscript. TheauthorswouldliketothankErikSneldersforhis outstandingsecretarialhelp.-
dc.language.isoen-
dc.publisher-
dc.rightsThe Author(s) 2022.Published by Oxford University Presson behalf of the ERA. Allrights reserved. For permissions, please e-mail: journals.permissions@oup.com. Free access-
dc.titleSeroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis-
dc.typeJournal Contribution-
dc.identifier.epage1575-
dc.identifier.issue8-
dc.identifier.spage1566-
dc.identifier.volume37-
local.format.pages10-
local.bibliographicCitation.jcatA1-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1093/ndt/gfac174-
local.provider.typeCrossRef-
local.uhasselt.internationalno-
item.fullcitationVerleye, Arno; Wijtvliet, Veerle; ABRAMS, Steven; Hellemans, Rachel; Bougrea, Rania; Massart, Annick; Pipeleers, Lissa; Wissing, Karl Martin; Ariën, Kevin K; De Winter, Benedicte Y; Van Damme, Pierre; Abramowicz, Daniel & Ledeganck, Kristien J (2022) Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis. In: Nephrology, dialysis, transplantation, 37 (8) , p. 1566 -1575.-
item.accessRightsOpen Access-
item.contributorVerleye, Arno-
item.contributorWijtvliet, Veerle-
item.contributorABRAMS, Steven-
item.contributorHellemans, Rachel-
item.contributorBougrea, Rania-
item.contributorMassart, Annick-
item.contributorPipeleers, Lissa-
item.contributorWissing, Karl Martin-
item.contributorAriën, Kevin K-
item.contributorDe Winter, Benedicte Y-
item.contributorVan Damme, Pierre-
item.contributorAbramowicz, Daniel-
item.contributorLedeganck, Kristien J-
item.fulltextWith Fulltext-
item.validationvabb 2024-
crisitem.journal.issn0931-0509-
crisitem.journal.eissn1460-2385-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273.pdfPublished version772.2 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

12
checked on Oct 13, 2025

WEB OF SCIENCETM
Citations

11
checked on Sep 3, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.